category

Earnings Report

Under Armour Investors Punish CEO Kevin Plank

The stock is seeing its biggest single-day loss in eight years, amid heavy volume, even as Plank downplayed concerns about the company’s declining growth rate on Tuesday.

Under Armour Investors Punish CEO Kevin Plank

The stock is seeing its biggest single-day loss in eight years, amid heavy volume, even as Plank downplayed concerns about the company’s declining growth rate on Tuesday.

United Tech Beats Forecasts, Narrows Forecast

United Technologies beat analysts' profit and sales estimates with third-quarter results on Tuesday, and notched up the low end of its full-year profit forecast, sending shares higher in pre-market trading.

United Tech Beats Forecasts, Narrows Forecast

United Technologies beat analysts' profit and sales estimates with third-quarter results on Tuesday, and notched up the low end of its full-year profit forecast, sending shares higher in pre-market trading.

3M Trims Forecasts For Second Time, Shares Fall

3M, the maker of Scotch tape and Post-it notes, trimmed its full-year revenue and earnings forecasts for the second time as it struggles with slowing sales in emerging markets.

3M Trims Forecasts For Second Time, Shares Fall

3M, the maker of Scotch tape and Post-it notes, trimmed its full-year revenue and earnings forecasts for the second time as it struggles with slowing sales in emerging markets.

Procter & Gamble's 1Q Results Topped Expectations

Procter & Gamble, the maker of Tide detergent and Pampers diapers, on Tuesday reported better-than-expected quarterly sales, helped by strong demand for its baby, feminine and home care products.

Procter & Gamble's 1Q Results Topped Expectations

Procter & Gamble, the maker of Tide detergent and Pampers diapers, on Tuesday reported better-than-expected quarterly sales, helped by strong demand for its baby, feminine and home care products.

Merck Reports Better Than Expected 3Q Earnings

Dow component Merck reported an adjusted 3Q profit of $1.07 per share, topping the estimate for $0.99. Revenue for the drugmaker came in at $10.54 billion, also beating the estimate for $10.17 billion

Merck Reports Better Than Expected 3Q Earnings

Dow component Merck reported an adjusted 3Q profit of $1.07 per share, topping the estimate for $0.99. Revenue for the drugmaker came in at $10.54 billion, also beating the estimate for $10.17 billion